ERBB2 and interstitial lung disease: Compared to patients with low HER-2 expression, HER-2-positive patients had a higher incidence and severity of AEs, particularly interstitial lung disease (ILD)/pneumonia, with some patients experiencing grade 5 ILD/pneumonia, leading to discontinuation or death [38–42].